CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0362

Sildenafil Raw

Filed under Raw Materials. The bureau holds 62 laboratory returns for this compound from 18 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

18 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A710.09.910.024 May 202624 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693A710.09.910.014 Nov 202516 Apr 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A89.18.010.024 May 202624 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A58.97.410.023 May 202623 May 2026
Eros PeptidesCASE #VI-2026-0918X18.98.98.92 Jul 20252 Jul 2025
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A78.57.09.923 May 202623 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A68.56.510.024 May 202624 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A88.47.79.424 May 202624 May 2026
Xingtai Jiachuang TechnologyCASE #VI-2026-0712X18.38.38.32 Apr 20252 Apr 2025
Hunan GoodPeptides Biotech CoCASE #VI-2026-0370X17.97.97.921 May 202521 May 2025
Mai PeptideCASE #VI-2026-0769X57.86.810.02 Apr 202520 May 2026
Kerisite Shenzhen InternationalCASE #VI-2026-0315X17.87.87.87 May 20257 May 2025
ZhuoYan labCASE #VI-2026-0902X27.15.09.211 Jun 202526 Jan 2026
Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558X16.76.76.725 Apr 202525 Apr 2025
Rayshine Peptide BiochemicalsCASE #VI-2026-0545X16.36.36.327 Feb 202527 Feb 2025
HybiopeptidesCASE #VI-2026-0305X14.04.04.014 Jan 202514 Jan 2025
Shaanxi Dideu MedichemCASE #VI-2026-0499X13.93.93.913 Jun 202513 Jun 2025
Wuhan Newtop BiotechCASE #VI-2026-0676X10.00.00.03 Jul 20253 Jul 2025

Open any subject to view the batch-level evidence for Sildenafil Raw alone.